Related Experiment Video
Updated: Jul 25, 2025
Production and Targeting of Monovalent Quantum Dots
Published on: October 23, 2014
Two-Step Preparation of Protein-Decorated Biohybrid Quantum Dot Nanoparticles for Cellular Uptake
Agata Noelia Traverso1, David José Fragale1, Diego Luis Viale1
1Neuro and Molecular Cytogenetics Laboratory, Institute of Emerging Technologies and Applied Sciences (ITECA), National Council for Scientific and Technical Research (CONICET), School of Science and Technology, National University of San Martín, Av. Gral. Paz 5445, San Martín B1650, Argentina.
We developed a simple method to create targeted nanoparticles for cancer therapy. These biohybrid nanoparticles selectively target and deliver drugs to cancer cells, showing promise for improved treatments.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Cell Biology
Background:
- Effective nanoparticle decoration is crucial for targeted cell recognition and internalization.
- Current methods often result in nonspecific interactions, hindering targeted delivery.
- Developing robust biohybrid nanoparticles is essential for advanced therapeutic applications.
Purpose of the Study:
- To establish a straightforward two-step procedure for preparing biohybrid nanoparticles.
- To investigate the targeting specificity and therapeutic efficacy of decorated nanoparticles.
- To evaluate the in vivo cell uptake and traceability of these novel nanostructures.
Main Methods:
- Preparation of quantum dot (QD) core nanoparticles coated with human serum albumin (HSA) using ultrasonication and glutaraldehyde crosslinking.
- Decoration of nanoparticles with native human serum albumin (HSA) or human transferrin (HTF).
- Characterization of nanoparticle size, fluorescence retention, and serum stability; assessment of cellular uptake in cancer and neuronal cell lines; evaluation of drug delivery efficacy; in vivo imaging in murine retinal cells.
Main Results:
- Homogeneous biohybrid nanoparticles (20-30 nm) were successfully prepared, retaining QD fluorescence and resisting the "corona effect".
- Transferrin-decorated QD nanoparticles showed selective uptake in A549 lung cancer and SH-SY5Y neuroblastoma cells, but not in non-cancerous cells.
- Digitoxin-loaded transferrin-decorated nanoparticles effectively reduced A549 cancer cell numbers, with no impact on non-cancerous cells; in vivo studies demonstrated selective targeting and traceability in murine retinal cells.
Conclusions:
- The developed two-step procedure yields stable, non-aggregating biohybrid nanoparticles with preserved biological properties.
- Transferrin decoration enables selective targeting of cancer and neuroblastoma cells, facilitating targeted drug delivery.
- These biohybrid nanoparticles offer a promising platform for targeted therapy and in vivo cell imaging with high specificity.
